Waddill William D. Insider Trades

Insider Trading History

Track insider trading activity for Waddill William D.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Director
Holding Value $2.28M 16,825 shares
Last Trade
Jun 23, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.07M 9,000 shares
$118.96
$135.46
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Director
Holding Value $0 0 shares
Last Trade
Jun 23, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.07M 9,000 shares
$118.96
$135.46
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Director
Holding Value $1.06M 7,825 shares
Last Trade
Jun 23, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.06M 9,000 shares
$117.94
$135.46
Annexon
Annexon ANNX
Director
Holding Value $423k 65,000 shares
Last Trade
Jun 11, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$306k 65,000 shares
$4.70
$6.50
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Director
Holding Value $1.22M 9,000 shares
Last Trade
Jun 10, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$952k 9,000 shares
$105.77
$135.46
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Director
Holding Value $2.28M 16,825 shares
Last Trade
Jun 10, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$952k 9,000 shares
$105.77
$135.46
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Director
Holding Value $1.06M 7,825 shares
Last Trade
Jun 10, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$969k 9,000 shares
$107.68
$135.46
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Director
Holding Value $406k 3,000 shares
Last Trade
May 29, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$896k 9,000 shares
$99.56
$135.46
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Director
Holding Value $2.28M 16,825 shares
Last Trade
May 29, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$896k 9,000 shares
$99.56
$135.46
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Director
Holding Value $1.06M 7,825 shares
Last Trade
May 29, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$897k 9,000 shares
$99.64
$135.46
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Director
Holding Value $3.77M 27,825 shares
Last Trade
Feb 06, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.69M 20,000 shares
$84.49
$135.46
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Director
Holding Value $0 0 shares
Last Trade
Feb 06, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.69M 20,000 shares
$84.49
$135.46
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Director
Holding Value $1.06M 7,825 shares
Last Trade
Feb 06, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.67M 20,000 shares
$83.68
$135.46
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Director
Holding Value $1.06M 7,825 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$563k 6,457 shares
$87.18
$135.46
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals ARWR
Director
Holding Value $4.49M 62,514 shares
Last Trade
Dec 19, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$566k 8,367 shares
$67.66
$71.82
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals ARWR
Director
Holding Value $4.66M 64,930 shares
Last Trade
Dec 16, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$506k 7,819 shares
$64.66
$71.82
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Director
Holding Value $1.78M 13,130 shares
Last Trade
Oct 10, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$979k 12,000 shares
$81.62
$135.46
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Director
Holding Value $0 0 shares
Last Trade
Oct 10, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.04M 12,000 shares
$87.00
$135.46
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Director
Holding Value $2.32M 17,130 shares
Last Trade
Oct 10, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.04M 12,000 shares
$87.00
$135.46
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Director
Holding Value $695k 5,130 shares
Last Trade
Sep 22, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$257k 4,000 shares
$64.25
$135.46

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up